plerixafor has been researched along with Brucellosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arayan, LT; Huy, TXN; Kang, CK; Kim, S; Lee, HJ; Lee, JH; Min, W; Reyes, AWB; Vu, SH | 1 |
1 other study(ies) available for plerixafor and Brucellosis
Article | Year |
---|---|
Chemokine receptor 4 (CXCR4) blockade enhances resistance to bacterial internalization in RAW264.7 cells and AMD3100, a CXCR4 antagonist, attenuates susceptibility to Brucella abortus 544 infection in a murine model.
Topics: Animals; Benzylamines; Brucella abortus; Brucellosis; Cell Survival; Cyclams; Disease Susceptibility; Female; Heterocyclic Compounds; Mice; Mice, Inbred BALB C; Models, Biological; RAW 264.7 Cells; Receptors, CXCR4; Specific Pathogen-Free Organisms | 2019 |